Navigation Links
Environmentally friendly chemistry important for manufacturing pharmaceuticals
Date:11/8/2012

Limiting the quantity of catalysts substances that trigger a chemical reaction used in the manufacture of pharmaceuticals is important, and research from the University of Gothenburg, Sweden, has now demonstrated that small quantities of copper work well in this respect.

"This is an important finding, not just academically but also for industry," says chemist Per-Fredrik Larsson.

Catalysis is an incredibly valuable tool in the field of chemistry, with the Haber-Bosch process being one of the most important catalytic processes in the world. It is used to manufacture fertilizer, and calculations show that without it the world's population would be just half of what it is today.

Precious metals are often used as catalysts in organic chemistry as they enable the production of many organic molecules with applications in areas such as pharmaceuticals and fine chemicals. As recently as 2010 Richard F. Heck, Ei-ichi Negishi and Akira Suzuki were awarded the Nobel Prize in Chemistry for their work on palladium catalysis.

"A problem with precious metals like palladium is that they are both expensive and harmful to the environment," says Per-Fredrik Larsson at the Department of Chemistry and Molecular Biology.

Recent years have seen researchers evaluating several different non-precious metals primarily iron and copper as cheap and environmentally friendly alternatives to precious metals.

"Iron catalysts have proven to be a competitive alternative to precious metals for a number of reactions," says Per-Fredrik Larsson. "An in-depth understanding of how these reactions work is incredibly important if we are to take this further. The results from our studies with iron led to several important insights into just how complex the chemistry can be."

Larsson's research group works not only with experimental methods but also with calculation models to understand how the chemistry works.

The trend for swapping precious metals for non-precious alternatives also has a flipside. It was discovered during experiments with iron catalysis in conjunction with professor Carsten Bolm of RWTH Aachen University in Germany that some reactions thought to be catalysed by iron had actually been catalysed by traces of copper in the commercially available iron source.

The fact that traces of copper could catalyse a number of different reactions was surprising as copper had previously been thought to be an ineffective catalyst requiring large quantities and high reaction temperatures.

"Our results show that copper has been given an undeservedly bad name as a catalyst," says Per-Fredrik Larsson. "Given that copper chemistry is over a century old, it's surprising that nobody's realised this before."

It is important in the pharmaceutical industry to limit the use of catalysts as the quantity of metal in the end-product is strictly regulated and the recovery process can be both difficult and expensive. As such, the finding that small quantities of copper can be used is an important discovery.

"We've developed and studied reactions with small quantities of copper and tried to understand how and why they work," says Per-Fredrik Larsson.

The results and conclusions for iron and copper catalysts are a major contribution to this field of research and are important for its continued development.


'/>"/>
Contact: Per-Fredrik Larsson
per-fredrik.larsson@chem.gu.se
46-031-786-9104
University of Gothenburg
Source:Eurekalert

Related medicine news :

1. Nanoparticles detect biochemistry of inflammation
2. UGA chemistry discovery could have major medical implications
3. Heroes of Chemistry: Developed new drugs and technology to cut heating and cooling bills
4. Government can play important role in obesity epidemic
5. Cancer turns off important immune cells, complicating experimental vaccine therapies
6. Timing of antibiotics important in reducing infections after C-section
7. An important breakthrough in immunology by IRCM researchers
8. Higher hospital volume more important than surgeon experience in outcome of prostate cancer surgery
9. Joslin scientists identify important mechanism that affects the aging process
10. Moffitt Cancer Center researchers: Quality of life as important as quantity of life
11. Timing pregnancy an important health concern for women
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... ... , ... Marcy was in a crisis. Her son James, eight, was out of control. Prone ... physically. , “When something upset him, he couldn’t control his emotions,” remembers Marcy. “If ... at my other children and say he was going to kill them. If we ...
(Date:6/24/2016)... ... June 24, 2016 , ... Dr. Amanda Cheng, an ... Dr. Cheng has extensive experience with all areas of orthodontics, including robotic Suresmile ... orthodontics. , Micro-osteoperforation is a revolutionary adjunct to orthodontic treatment. It can ...
(Date:6/24/2016)... ... June 24, 2016 , ... People across the U.S. are sharpening ... Talker Award, an essay contest in which patients and their families pay tribute to ... at the 2016 National Society of Genetic Counselors (NSGC) Annual Education Conference (AEC) this ...
(Date:6/24/2016)... ... 24, 2016 , ... Puradigm® & Innovative Solutions today announced ... and processing operations at its production facility, and opened its first two dispensaries ... manufacturer of a complete system of proactive air and surface purification solutions for ...
(Date:6/24/2016)... ... , ... Venture Construction Group (VCG) sponsors Luke’s Wings ... the Woodmont Country Club at 1201 Rockville Pike, Rockville, Maryland, 20852. The event ... that have been wounded in battle and their families. Venture Construction Group is a ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... LEXINGTON, Mass. , June 24, 2016   ... specialty pharmaceutical company developing innovative inhaled drugs, announced today ... when Russell Investments reconstituted its comprehensive set ... 2016. "This is an important milestone for ... "It will increase shareholder awareness of our progress in ...
(Date:6/23/2016)... Research and Markets has announced the ... to 2022" report to their offering. ... patients with kidney failure, it replaces the function of kidneys ... blood and thus the treatment helps to keep the patient ... Increasing number of ESRD patients & substantial ...
(Date:6/23/2016)... Roche (SIX: RO, ROG; OTCQX: RHHBY) announced ... BRAHMS PCT (procalcitonin) assay as a dedicated testing solution ... this clearance, Roche is the first IVD company in ... sepsis risk assessment and management. PCT is ... levels in blood can aid clinicians in assessing the ...
Breaking Medicine Technology: